316 related articles for article (PubMed ID: 23432584)
21. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
Amdii RE; Al' Shukri AS
Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
[TBL] [Abstract][Full Text] [Related]
22. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
23. A phytosterol-enriched saw palmetto supercritical CO
Sudeep HV; Venkatakrishna K; Amrutharaj B; Anitha ; Shyamprasad K
BMC Complement Altern Med; 2019 Oct; 19(1):270. PubMed ID: 31623582
[TBL] [Abstract][Full Text] [Related]
24. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
[TBL] [Abstract][Full Text] [Related]
25. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
[TBL] [Abstract][Full Text] [Related]
26. Botanical derivatives for the prostate.
Cristoni A; Di Pierro F; Bombardelli E
Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
[TBL] [Abstract][Full Text] [Related]
27. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
Hizli F; Uygur MC
Int Urol Nephrol; 2007; 39(3):879-86. PubMed ID: 17203353
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia.
Bernichtein S; Pigat N; Camparo P; Latil A; Viltard M; Friedlander G; Goffin V
Prostate; 2015 May; 75(7):706-22. PubMed ID: 25683150
[TBL] [Abstract][Full Text] [Related]
30. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
[TBL] [Abstract][Full Text] [Related]
31.
Saponaro M; Giacomini I; Morandin G; Cocetta V; Ragazzi E; Orso G; Carnevali I; Berretta M; Mancini M; Pagano F; Montopoli M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276425
[TBL] [Abstract][Full Text] [Related]
32. Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia.
Colado-Velázquez J; Mailloux-Salinas P; Medina-Contreras J; Cruz-Robles D; Bravo G
Phytother Res; 2015 Oct; 29(10):1525-31. PubMed ID: 26104840
[TBL] [Abstract][Full Text] [Related]
33. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
Plosker GL; Brogden RN
Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
[TBL] [Abstract][Full Text] [Related]
34. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
[TBL] [Abstract][Full Text] [Related]
35. Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.
Saidi S; Stavridis S; Stankov O; Dohcev S; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):123-129. PubMed ID: 28991765
[TBL] [Abstract][Full Text] [Related]
36. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
37. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia.
Vela-Navarrete R; Escribano-Burgos M; Farré AL; García-Cardoso J; Manzarbeitia F; Carrasco C
J Urol; 2005 Feb; 173(2):507-10. PubMed ID: 15643230
[TBL] [Abstract][Full Text] [Related]
38. Saw palmetto and benign prostatic hyperplasia.
Gong EM; Gerber GS
Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
[TBL] [Abstract][Full Text] [Related]
39. [Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice].
Kuzmenko AV; Gyaurgiev TA; Kuzmenko GA
Urologiia; 2022 May; (2):84-89. PubMed ID: 35485819
[TBL] [Abstract][Full Text] [Related]
40. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.
Buck AC
J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]